Faculty
Associate Professor of Medicine, Director, Thoracic Oncology Head, Developmental Therapeutics Lombardi Comprehensive Cancer Center Georgetown University, Washington, DC
Dr. Stephen V. Liu, MD, is a thoracic medical oncologist and the Chief of the Division of Hematology & Oncology at Georgetown University. He is an Associate Professor of Medicine at Georgetown University at Georgetown University School of Medicine. He is the Head of Developmental Therapeutics at the Georgetown University Lombardi Comprehensive Cancer Center. He is also co-host of the official IASLC podcast, Lung Cancer Considered. Dr. Liu completed medical training at the University of Pennsylvania and hematology and oncology fellowship at the University of Southern California. He has been on the Georgetown faculty since 2013.
Assistant Professor of Medicine in the Division of Medical
Oncology at Washington University School of Medicine and Siteman Cancer Center in St.
Louis, Missouri
Jeffrey P. Ward, MD, PhD, is an Assistant Professor of Medicine in the Division of Medical Oncology at Washington University School of Medicine and Siteman Cancer Center in St. Louis, Missouri. A physician-scientist with subspecialty expertise in thoracic malignancies, Dr. Ward has a dedicated clinical and research focus in small cell lung cancer, including active involvement in clinical trials evaluating novel immunotherapeutic strategies, including bispecific T-cell engagers, personalized neoantigen vaccines, and investigational cellular therapies. He has presented widely on the evolving treatment landscape in SCLC for both academic and community oncology audiences and is a member of ASCO, IASLC, AACR, and SITC.
Associate Member, Department of Thoracic Oncology
Associate Professor, Department of Oncologic Sciences, University of South Florida
Clinical Research Medical Director, Department of Thoracic Oncology
Moffitt Cancer Center, Tampa, Florida
Dr. Sonam Puri is a thoracic medical oncologist and Associate Member at Moffitt Cancer Center, where she serves as Clinical Research Medical Director for Thoracic Oncology and solid tumor lead for the innovative T-cell engager inpatient service (SONIC). Dr. Puri plays active roles in shaping national guidelines as Chair of the ASCO Living Guidelines for Stage IV NSCLC and Deputy Chair of the IASLC Membership Committee. Her research integrates biomarker-driven trial design with translational collaborations, aiming to accelerate the development of novel therapies and improve patient care.
Assistant Professor, Medical Oncology
MUSC Health Hematology Oncology at Hollings Cancer Center, Charleston, South Carolina
Assistant Professor of Medicine, Indiana University School of Medicine
Adjunct Assistant Professor of Medical & Molecular Genetics
Associate Member, Experimental and Developmental Therapeutics
Department of Medicine, Division of Hematology/Oncology, Thoracic Oncology
Indiana University Melvin & Bren Simon Comprehensive Cancer Center, Indianapolis, IN
Dr. Misty Dawn Shields is a thoracic medical oncologist, assistant professor of clinical medicine, adjunct assistant professor of medical and molecular genetics, and associate member of experimental and developmental therapeutics at Indiana University School of Medicine and Indiana University Health Physicians. The fight against lung cancer is personal. She lost her father to small cell lung cancer when she was 15 years old. After losing her father, she sought to better understand every piece of bench-to-bedside precision medicine for lung cancer. Dr. Shields trained with world-renowned translational oncologist Dr. John Minna, where her graduate studies helped to identify predictive biomarkers to pemetrexed in non-small cell lung cancer. In collaboration with the laboratory of Dr. Melanie Cobb, she contributed to the discovery of NeuroD1 as a neuroendocrine subtype in small cell lung cancer. To serve at the bedside and care for patients experiencing similar afflictions to her father, Dr. Shields steadfastly pursued her medical training at UT Houston, including rotations at MD Anderson Cancer Center, internal medicine residency at Vanderbilt University, hematology/oncology fellowship at H. Lee Moffitt Cancer Center as chief fellow, and the FDA-AACR Oncology Educational fellowship. She joined faculty at Indiana University in August 2022 as a physician scientist with a focus in early phase trials, longitudinal liquid biopsies, and translational studies for novel therapeutics in acquired chemo-resistant SCLC as principal investigator of the Shields laboratory. Dr. Shields serves on the guideline panel for SCLC with the National Comprehensive Cancer Network, local leadership board for American Lung Association, ASCO Scientific Program Committee for Lung Cancer - Non-small Cell Local-regional/Small Cell/Other Track, IASLC Rare Tumors Committee for SCLC, and as the clinical trials advocate for IU Simon Comprehensive Cancer Center’s End Lung Cancer Now. She was the recipient of the ASCO Conquer Cancer Career Development Award in 2025. Dr. Shields is the founder of Small Cell SMASHERS, a patient advocacy group for small cell lung cancer in partnership with Lungevity Foundation.
Director, Lung Cancer Research Greco Hainsworth Centers for Research Tennessee Oncology, Nashville, Tennessee
Assistant Professor, Department of General Oncology, Division of Cancer Medicine
Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology,
The University of Texas MD Anderson Cancer Center, Houston, TX
Dr. Eric K. Singhi is an Assistant Professor and Thoracic Medical Oncologist at the University of Texas MD Anderson Cancer Center. He completed his Internal Medicine residency at Vanderbilt University and served as Chief Hematology/Oncology fellow at MD Anderson during his training. As faculty at MD Anderson, Dr. Singhi specializes in patient education research and young onset lung cancer research. Internally, he serves as Medical Oncology Lead of the MD Anderson Young-Onset Lung Cancer Program, Patient Safety and Quality Officer for the Thoracic Medical Oncology Service Line, Director of Thoracic Research for the MD Anderson Cancer Network, and Director of the Thoracic Medical Oncology rotation for the MD Anderson medical oncology fellowship program. Nationally, he serves on the IASLC Communications Committee and ASCO NSCLC Guidelines Committee.